Emerging CAR T cells therapies: clinical landscape and patent technological routes.
Clicks: 348
ID: 67241
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
63.0
/100
348 views
241 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #11 of 39 articles by views in human vaccines & immunotherapeutics
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The purpose of this study is to mine CAR-T patents and therapies under development, to design a landscape of the sector and to understand key therapy segments and their current trends. The study analyzed the entire market, consisting of 1624 patent families and 509 biologics under development, to depict an overview of the CAR-T therapies and their state of the art. Our results showed cutting-edge inventions, the major players, the dynamics of cooperation among institutions, the progress of the therapies' generation over the years and future innovation pathways. CAR-T therapies are transforming the current scenario for cancer treatment, and this study reveals the picture of what we can likely expect ahead in order to assist scientists at the academy and industry to improve their research strategies.
| Reference Key |
picancocastro2019emerginghuman
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Picanco-Castro, Virgínia;Gonçalves Pereira, Cristiano;Swiech, Kamilla;Ribeiro Malmegrim, Kelen Cristina;Tadeu Covas, Dimas;Silveira Porto, Geciane; |
| Journal | human vaccines & immunotherapeutics |
| Year | 2019 |
| DOI |
10.1080/21645515.2019.1689744
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.